FDA Inspection 1112542 — FXM Clinical Research Miramar LLC
The FDA completed an inspection of FXM Clinical Research Miramar LLC on November 21, 2019 in Miramar, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 21, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Miramar, FL (United States)
Additional Details
Clinical BA/BE